Overview

Rectal Misoprostol Versus Sublingual Misoprostol Prior to Myomectomy

Status:
Completed
Trial end date:
2020-04-30
Target enrollment:
Participant gender:
Summary
the aim of the study is To compare the effectiveness of rectally administered prostaglandin E1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before myomectomy to decrease blood loss during and after the operation.
Phase:
Phase 4
Details
Lead Sponsor:
Assiut University
Treatments:
Misoprostol